BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+7.31%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$164M
AUM Growth
+$164M
(+3%)
Cap. Flow
-$1.1M
Cap. Flow
% of AUM
-0.67%
Top 10 Holdings %
Top 10 Hldgs %
85.32%
Holding
58
New
4
Increased
8
Reduced
3
Closed
4
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$1.09M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$956K |
| 3 |
VRML
Vermillion, Inc.
VRML
|
$890K |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$826K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$766K |
Top Sells
| 1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$5.79M |
| 2 |
InflaRx
IFRX
|
$605K |
| 3 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$387K |
| 4 |
CELG
Celgene Corp
CELG
|
$124K |
| 5 |
Veracyte
VCYT
|
$114K |
Sector Composition
| 1 | Healthcare | 96.53% |
| 2 | Energy | 1.97% |
| 3 | Consumer Staples | 0.07% |
| 4 | Consumer Discretionary | 0.05% |
| 5 | Materials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
XBiotech
XBIT
$96.3M
| $76K | 0.05% |
10,000
| – | – |
|
52
Workhorse Group
WKHS
$20.3M
| $74K | 0.05% |
25,000
| – | – |
|
|
LTHM
53
DELISTED
Livent Corporation
LTHM
| $69K | 0.04% |
10,000
| – | – |
|
|
GNMX
54
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $20K | 0.01% |
128,000
| – | – |
|
|
55
InflaRx
IFRX
$108M
| – | – |
-16,000
| Closed | -$605K |
|
|
SITO
56
DELISTED
SITO MOBILE, LTD
SITO
| – | – |
-40,000
| Closed | -$73K |
|
|
CMTA
57
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| – | – |
-222,000
| Closed | -$5.79M |
|
|
OMED
58
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| – | – |
-372,557
| Closed | -$387K |
|